The Papain-Like proteases (PLpro) of SARS-CoV-2 play a crucial role in viral replication and the formation of nonstructural proteins. To find available inhibitors, the 3D structure of PLpro of SARS2 was obtained by homologous modelling, and we used this structure as a target to search for inhibitors through molecular docking and MM/GBSA binding free energy rescoring. A novel hydrogen bonding penalty was applied to the screening process, which meanwhile took desolvation into account. Finally, 61 compounds were acquired and 4 of them with IC50 at micromolar level tested in vitro enzyme activity assay, which includes clinical drugs tegaserod. Considering the importance of crystal water molecules, the 4 compounds were re-docked and considered b...
Two proteases produced by the SARS-CoV-2 virus, the main protease and papain-like protease, are esse...
Drugs targeting SARS-CoV-2 could have saved millions of lives during the COVID-19 pandemic, and it i...
In the month of December 2019, the outbreak of COVID-19 disease in China marked the beginning of a g...
The papain-like protease (PLpro) of SARS-CoV-2 is a validated antiviral drug target. Through a fluor...
The papain-like protease (PLpro) is vital for the replication of coronaviruses (CoVs), as well as fo...
The rapid global spread of the SARS-CoV-2 virus facilitated the development of novel direct-acting a...
SARS-CoV-2 PLpro was investigated as a therapeutic target for potent antiviral drugs due to its esse...
The indispensable role of the SARS-CoV-2 main protease (Mpro) in the viral replication cycle and its...
SARS-CoV-2 causes the current global pandemic coronavirus disease 2019. Widely-available effective d...
The pandemic of coronavirus disease 2019 (COVID-19) is changing the world like never before. This cr...
The incidence of 2019 novel corona virus (SARS-CoV-2) has created a medical emergency throughout the...
Papain-like protease is an essential enzyme in the proteolytic processing required for the replicati...
Background: A significant worry for global public health is the international spread of the coronavi...
During almost all 2020, coronavirus disease 2019 (COVID-19) pandemic has constituted the major risk ...
During almost all 2020, coronavirus disease 2019 (COVID-19) pandemic has constituted the major risk ...
Two proteases produced by the SARS-CoV-2 virus, the main protease and papain-like protease, are esse...
Drugs targeting SARS-CoV-2 could have saved millions of lives during the COVID-19 pandemic, and it i...
In the month of December 2019, the outbreak of COVID-19 disease in China marked the beginning of a g...
The papain-like protease (PLpro) of SARS-CoV-2 is a validated antiviral drug target. Through a fluor...
The papain-like protease (PLpro) is vital for the replication of coronaviruses (CoVs), as well as fo...
The rapid global spread of the SARS-CoV-2 virus facilitated the development of novel direct-acting a...
SARS-CoV-2 PLpro was investigated as a therapeutic target for potent antiviral drugs due to its esse...
The indispensable role of the SARS-CoV-2 main protease (Mpro) in the viral replication cycle and its...
SARS-CoV-2 causes the current global pandemic coronavirus disease 2019. Widely-available effective d...
The pandemic of coronavirus disease 2019 (COVID-19) is changing the world like never before. This cr...
The incidence of 2019 novel corona virus (SARS-CoV-2) has created a medical emergency throughout the...
Papain-like protease is an essential enzyme in the proteolytic processing required for the replicati...
Background: A significant worry for global public health is the international spread of the coronavi...
During almost all 2020, coronavirus disease 2019 (COVID-19) pandemic has constituted the major risk ...
During almost all 2020, coronavirus disease 2019 (COVID-19) pandemic has constituted the major risk ...
Two proteases produced by the SARS-CoV-2 virus, the main protease and papain-like protease, are esse...
Drugs targeting SARS-CoV-2 could have saved millions of lives during the COVID-19 pandemic, and it i...
In the month of December 2019, the outbreak of COVID-19 disease in China marked the beginning of a g...